AWAP
GSK icon

Alliance Wealth Advisors (Pennsylvania)’s GSK GSK Stock Holding History

Alliance Wealth Advisors (Pennsylvania)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$437K Sell
8,329
-744
-8% -$39.3K 0.14% 99
2026
Q1 		$501K Sell
9,073
-302
-3% -$16.4K 0.22% 76
2025
Q4 		$460K Buy
9,375
+61
+0.7% +$2.85K 0.2% 83
2025
Q3 		$402K Buy
9,314
+74
+0.8% +$2.89K 0.18% 97
2025
Q2 		$355K Buy
9,240
+65
+0.7% +$2.48K 0.18% 105
2025
Q1 		$355K Buy
9,175
+257
+3% +$9.41K 0.2% 94
2024
Q4 		$302K Buy
8,918
+1,688
+23% +$60.8K 0.17% 111
2024
Q3 		$296K Sell
7,230
-6
-0.1% -$245 0.17% 115
2024
Q2 		$279K Sell
7,236
-69
-0.9% -$2.9K 0.18% 110
2024
Q1 		$313K Sell
7,305
-56
-0.8% -$2.31K 0.2% 103
2023
Q4 		$273K Sell
7,361
-506
-6% -$18.2K 0.18% 107
2023
Q3 		$285K Buy
+7,867
New +$279K 0.21% 95

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SP
Stablepoint Partners Braintree, Massachusetts $723M AUM 29.31% 1-Year Est. Return

Alliance Wealth Advisors (Pennsylvania)'s GSK Position: Q2 2026 in Review

Alliance Wealth Advisors (Pennsylvania) reduced its GSK (GSK) stake by 8.2% in Q2 2026, selling an estimated $39.3K and leaving 8,329 shares worth $437K. The position accounts for 0.14% of the portfolio, ranked #99.

Alliance Wealth Advisors (Pennsylvania) first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $501K in Q1 2026. 145 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Alliance Wealth Advisors (Pennsylvania) held 8,329 shares of GSK worth $437K as of Q2 2026.
  • Alliance Wealth Advisors (Pennsylvania) sold 744 GSK shares in Q2 2026, an estimated $39.3K.
  • GSK made up 0.14% of Alliance Wealth Advisors (Pennsylvania)'s portfolio in Q2 2026, its #99 holding.
  • Alliance Wealth Advisors (Pennsylvania) first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
  • Alliance Wealth Advisors (Pennsylvania)'s GSK position peaked at $501K in Q1 2026.
  • 145 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Alliance Wealth Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 9 Jul 2026.